Vimarsana
Biggest News Aggregation in the World

Page 29 - Inc View News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inc View. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inc View Today - Breaking & Trending Today

Cboe Global Markets, Inc.: Cboe Reports Record Q1 2023 Earnings With A 60% Increase in Diluted EPS - Vimarsana News

Cboe Global Markets, Inc.: Cboe Reports Record Q1 2023 Earnings With A 60% Increase in Diluted EPS

CHICAGO, IL / ACCESSWIRE / May 23, 2023 / Cboe Global Markets (BATS:CBOE) recently announced its earnings for the first quarter of 2023, showcasing record-breaking results. The company reported a 60% increase

QS Energy, Inc., Meaningful Progress and Notable Accomplishments - Vimarsana News

QS Energy, Inc., Meaningful Progress and Notable Accomplishments

Final engineering call with our new leading development partnerTOMBALL, TX / ACCESSWIRE / May 23, 2023 / QS Energy, Inc. (the "Company" or "QS Energy") (OTCQB:QSEP), a developer of integrated technology

Muscle Maker, Inc.: Muscle Maker Inc. Announces Agreement to Purchase Developed Farmland in Zambia for $8.5 Million USD - Vimarsana News

Muscle Maker, Inc.: Muscle Maker Inc. Announces Agreement to Purchase Developed Farmland in Zambia for $8.5 Million USD

The Acquisition Will Further Diversify Company's Holdings in the Agricultural VerticalFORT WORTH, TX / ACCESSWIRE / May 22, 2023 / Muscle Maker, Inc. (NASDAQ:GRIL) ("MMI" or the "Company"), a global agricultural-commodity

RTG Mining Inc.: Memorandum of Agreement Signed with TVI Resource Development Inc. - Vimarsana News

RTG Mining Inc.: Memorandum of Agreement Signed with TVI Resource Development Inc.

Not for release to US wire services or distribution in the United StatesAnnouncement to the Toronto Stock Exchange and Australian Securities ExchangeSUBIACO, WESTERN AUSTRALIA / ACCESSWIRE / May 22, 2023

Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces Presentation of Encouraging Preclinical Data for PRS-400 at ATS 2023 International Conference - Vimarsana News

Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces Presentation of Encouraging Preclinical Data for PRS-400 at ATS 2023 International Conference

BOSTON, MA / ACCESSWIRE / May 22, 2023 / Pieris Pharmaceuticals, Inc. (Nasdaq:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology